Aardvark Therapeutics, Inc. (AARD)

Aardvark Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Jun 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Market Capitalization	291	-	-	-
Enterprise Value	140	-	-	-
Debt / Equity Ratio	0.01	0.01	0.02	0.02
Quick Ratio	25.31	14.95	7.23	27.07
Current Ratio	25.86	15.05	7.50	27.72
Return on Equity (ROE)	-34.70%	-50.70%	-57.47%	-
Return on Assets (ROA)	-	-32.35%	-33.96%	-
Return on Capital (ROIC)	-24.18%	-34.67%	-36.34%	-
Buyback Yield / Dilution	-59.04%	-0.90%	-1.78%	-

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q